KAREX |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.81 MYR | -0.61% |
|
+1.89% | +10.96% |
| 26/02 | Karex Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
| 31/01 | Karex Berhad Announces Resignation of Lim Lee Kuan as Joint Secretary | CI |
| Sales 2024 * | 589M 124M 10.31B | Sales 2025 * | 669M 140M 11.71B | Capitalization | 853M 179M 14.93B |
|---|---|---|---|---|---|
| Net income 2024 * | 24M 5.04M 420M | Net income 2025 * | 44M 9.23M 770M | EV / Sales 2024 * | 1.62 x |
| Net Debt 2024 * | 98M 20.57M 1.71B | Net Debt 2025 * | 78M 16.37M 1.36B | EV / Sales 2025 * | 1.39 x |
| P/E ratio 2024 * |
36.8
x | P/E ratio 2025 * |
19.3
x | Employees | 3,396 |
| Yield 2024 * |
0.62% | Yield 2025 * |
1.11% | Free-Float | 39.47% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.61% | ||
| 1 week | +1.89% | ||
| Current month | +1.89% | ||
| 6 months | +42.11% | ||
| Current year | +10.96% |
1 week
0.79
0.82
1 month
0.780.91
Current year
0.680.91
1 year
0.510.91
3 years
0.330.91
5 years
0.261.23
10 years
0.263.16
| Managers | Title | Age | Since |
|---|---|---|---|
Miah Kiat Goh
CEO | Chief Executive Officer | 46 | 29/13/29 |
Chok Siang Goh
DFI | Director of Finance/CFO | 53 | 01/13/01 |
Leng Kian Goh
CTO | Chief Tech/Sci/R&D Officer | 69 | 27/12/27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fook Aun Chew
BRD | Director/Board Member | 62 | 17/23/17 |
Mun Wai Siew
BRD | Director/Board Member | 67 | 27/20/27 |
Miah Kiat Goh
CEO | Chief Executive Officer | 46 | 29/13/29 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 0.81 | -0.61% | 470,300 |
| 25/24/25 | 0.815 | 0.00% | 256,100 |
| 24/24/24 | 0.815 | +1.24% | 709,800 |
| 23/24/23 | 0.805 | 0.00% | 805,900 |
| 22/24/22 | 0.805 | +1.26% | 507,200 |
End-of-day quote BURSA MALAYSIA, April 26, 2024
More quotes
Karex Berhad is a Malaysia-based investment holding company. The Company has three segments. Sexual Wellness segment is engaged in the sale of condoms, personal lubricants and sex toys. Medical segment is engaged in the sale of catheters, probe covers, human immunodeficiency virus (HIV) and pregnancy test kits, and other medical related products. Other segment is engaged in the sale of products not related to sexual wellness and medical. Its subsidiaries, including Hevea Medical Sdn. Bhd., Innolatex Sdn. Bhd., Innolatex (Thailand) Limited, Karex Industries Sdn. Bhd. and Medical-Latex (Dua) Sdn. Bhd., are engaged in the manufacturing and selling of condoms, rubber products, personal lubricants and others. Its subsidiary, Karex Marketing Sdn. Bhd., is involved in manufacturing and selling hand sanitizers, condoms, personal lubricants and others. Its subsidiaries, Karex Global Limited, Karex Holdings Sdn. Bhd., Karex International Sdn. Bhd., are engaged in investment holding activity.
Sector
Personal Products
Calendar
30/05/2024
- Q3 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.81
MYR
Average target price
1.06
MYR
Spread / Average Target
+30.86%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +10.96% | 179M | |
| +89.62% | 342M | |
| -4.64% | 74.93M | |
| +6.23% | 65.87M |
- Stock Market
- Equities
- KAREX Stock
